PTB, a protein-protein interaction domain important for signal transduction;PTB, un domaine d'interaction proteine-proteine important dans le 'jeu de dominos' de la transmission du signal

Medecine/Sciences

Volumn 13, Issue 5, 1997, Pages 647-656

  Borg, Jean Paul ^a   Fournier, Emmanuel ^b   Margolis, Ben ^a   Birnbaum, Daniel ^b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CELL RECEPTOR; CYTOPLASM PROTEIN; INTEGRIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; PHOSPHOTYROSINE; PLECKSTRIN; PROTEIN; PROTEIN TYROSINE KINASE;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; COMPUTER ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0030979560     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/432     Document Type: Article

References (47)

1. Pawson T. Protein modules and signalling networks. Nature 1995; 373: 573-9.
2. Chardin P. Domaines SH2 et SH3: un nouveau paradigme pour la transmission du signal. Med Sci 1994; 10: 709-12.
3. Blaikie P, Immanuel D, Wu J, Li N, Yajnik V, Margolis B. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J Biol Chem 1994; 269: 32031-4.
4. Kavanaugh WM, Williams LT. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 1994; 266: 1862-5.
5. Gustafson T, He W, Craparo A, Schaub C, O'Neill T. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol Cell Biol 1995; 15: 2500-8.
6. Batzer AG, Blaikie P, Nelson K, Schlessinger J, Margolis B. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol Cell Biol 1995; 15: 4403-9.
7. Dikic I, Batzer AG , Blaikie P, Obermeier A, Ullrich A, Schlessinger J, Margolis B. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain. J Biol Chem 1995; 270: 15125-9.
8. Zhou MM, Ravichandran KS, Olejniczak ET, Petros AM, Meadows RP, Sattler M, Harlan JE, Wade WS, Burakoff SJ, Fesik SW. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature 1995; 378: 584-92.
9. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Pawson T, Pelicci PG. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992; 70: 93-104.
10. Fournier E, Rosnet O, Marchetto S, Turck CW, Rottapel R, Pelicci PG, Birnbaum D, Borg JP. Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase. J Biol Chem 1996; 271: 12956-63.
11. Tartare-Deckert S, Sawka-Verhelle D, Murdaca J, Van Obberghen E. Evidence for a differential interaction of SHC and IRS-1 with the IGF-IR in the yeast two-hybrid system. J Biol Chem 1995; 270: 23456-60.
12. Pratt JC, Weiss M, Sieff CA, Shoelson SE, Burakoff SJ, Ravichandran KS. Evidence for a physical association between the Shc-PTB domain and the be chain of the granulocyte-macrophage colony-stimulating factor. J Biol Chem 1996; 271: 12137.
13. Ravichandran KS, Igras V, Shoelson SE, Fesik SW, Burakoff SJ. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Proc Natl Acad Sci USA 1996; 93: 5275-80.
14. Trüb T, Choi WE , Wolf G, Ottinger E, Chen Y, Weiss M, Shoelson SE. Specificity of the PTB domain of Shc for β turn-forming pentapeptide motifs amino-terminal to phosphotyrosine. J Biol Chem 1995; 270: 18205-8.
15. Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G. The 145-kDa protein induced to associated with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci USA 1996; 93: 1689-93.
16. He W, O'Neill TJ, Gustafson TA. Distinct modes of interaction of SHC and IRS-1 with the insulin receptor NPEY region via non-SH2 domains. J Biol Chem 1995; 270: 23258-62.
17. Eck MJ, Dhe-Paganon S, Trüb T, Nolte RT, Shoelson SE. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 1996; 85: 695-705.
18. Waksman G, Kominos D, Robertson SC, Pant N, Baltimore D, Birge RB, Cowburn D, Hanafusa H, Mayer BJ, Overduin M. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 1992; 358: 646-53.
19. Mayor BJ, Ren R, Clark KL, Baltimore D. A putative modular domain present in diverse signaling proteins. Cell 1993; 73: 629-30.
20. Harlan JE, Hajduk PJ, Yoon HS, Fesik SW. Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature 1994; 371: 168-70.
21. Touhara K, Inglese J, Pitcher JA, Shaw G, Lefkowitz RJ. Binding of G protein beta gamma-subunits to pleckstrin homology domains. J Biol Chem 1994; 269: 10217-20.
22. Lemmon MA, Ferguson KM, Schlessinger J. PH domains : diverse sequences with a common fold recruit signaling molecules to the cell surface. Cell 1996; 85: 621-4.
23. Rameh LE, Chen CS, Cantley LC. Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins. Cell 1995; 83: 821-30.
24. Fournier E, Dubreuil P, Birnbaum D, Borg JP. Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor. Oncogene 1995; 11: 921-31.
25. Chen YH, Grall D , Salcini AE , Pelicci PG, Pouyssegur J, Van Obberghen-Schilling E. Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor. EMBO J 1996; 15: 1037-44.
26. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 1992; 360: 689-92.
27. He W, Craparo A, Zhu Y, O'Neill TJ, Wang LM, Pierce JH, Gustafson TA. Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors. J Biol Chem 1996; 271: 11641-5.
28. Myers MGJr, Sun XJ, White MF. The IRS-1 signaling system. Trends Biochem Sci 1994; 192: 289-93.
29. O'Bryan JP, Songyang Z, Cantley L, Der CJ, Pawson T. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain. Proc Natl Acad Sci USA 1996; 93: 2729-34.
30. Isakoff SJ, Yu YP, Su YC, Blaikie P, Yajnik V, Rose E, Weidner KM, Sachs M, Margolis B, Skolnik EY. The Shc PTB/PI domain is required for Shc tyrosine phosphorylation by the insulin receptor (IR) and recognizes an NPXY motif on the IR that is distinct from IRS-1 in vivo. J Biol Chem 1996; 271: 3959-62.
31. Chardin P. Protéines Ras et transmission des signaux mitogènes. Med Sci 1994; 10: 657-64.
32. Bork P, Margolis B. A phosphotyrosine interaction domain. Cell 1995; 80: 693-4.
33. Duclos F, Boschert U, Sirugo G, Mandel JL, Hen R, Koenig M. Gene in the region of the Friedreich ataxia locus encodes a putative transmembrane protein expressed in the nervous system. Proc Natl Acad Sci USA 1993; 90: 109-13.
34. Duilio A, Zambrano N, Mogavero AR, Ammendola R, Cimino F, Russo T. A rat brain mRNA encoding a transcriptional activator homologous to the DNA binding domain of retroviral integrases. Nucleic Acids Res 1991; 19: 5269-74.
35. Fiore F, Zambrano N, Minopoli G, Donini V, Duilio A, Russo T. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J Biol Chem 1996; 270: 30853-6.
36. Borg JP, Ooi J, Levy E, Margolis B. The PI domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 1996; 16: 6229-41.
37. Charest A, Wagner J, Jacob S, McGlade CJ, Tremblay ML. Phosphotyrosine-independent binding of SH-C to the NPLH sequence of murine protein-tyrosine phosphatase-PEST. J Biol Chem 1996; 271: 8424-9.
38. Yajnik V, Blaikie P, Bork P, Margolis B. Identification of residues within the Shc phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction. J Biol Chem 1996; 271: 1813-6.
39. Wu RY, Gill GN. LIM domain recognition of a tyrosine-containing tight turn. J Biol Chem 1994; 269: 25085-90.
40. Sudol M, Chen III, Bougeret C, Einbond A, Bork P. Characterization of a novel protein-binding module - the WW domain. FEBS Lett 1995; 369: 67-71.
41. Doyle DA, Lee A, Lewis J, Kim E, Sheng M, MacKinnon R. Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell 1996; 85: 1067-76.
42. Nishimoto I, Okamoto T, Matsuura Y, Takahashi S, Surayama Y, Ogata E. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go. Nature 1993; 362: 75-9.
43. Octave J, Macq A, Philippe B. Le pré curseur du peptide amyloïde de la maladie d'Alzheimer. Med Sci 1995; 11: 1251-9.
44. Selkoe DJ. Amyloid β protein and the genetics of Alzheimer's disease. J Biol Chem 1996; 271: 18295.
45. Chen WJ, Goldstein JL, Brown MS. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J Biol Chem 1990; 265: 3116-23.
46. Filardo EJ, Brooks PC, Deming SL, Damsky C, Cheresh DA. Requirement of the NPXY motif in the integrin β3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. J Cell Biol 1995; 130: 441-50.
47. Tran Van Nhieu G, Krukonis ES, Reszka AA, Horwitz AF, Isberg RR. Mutations in the cytoplasmic domain of the integrin β1 chain indicate a role for endocytosis factors in bacterial internalization. J Biol Chem 1996; 271: 7665-72.